GSA Capital Partners’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
GSA Capital Partners's TNDM Position: Q2 2026 in Review
GSA Capital Partners increased its Tandem Diabetes Care (TNDM) stake by 201% in Q2 2026, buying an estimated $792K and bringing the position to 67,901 shares worth $1.02M. The position accounts for 0.06% of the portfolio, ranked #492.
GSA Capital Partners first reported a position in TNDM in Q3 2018 and has held it in 15 quarters since. The position peaked at $2.5M in Q1 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- GSA Capital Partners held 67,901 shares of Tandem Diabetes Care worth $1.02M as of Q2 2026.
- GSA Capital Partners bought 45,365 Tandem Diabetes Care shares in Q2 2026, an estimated $792K.
- Tandem Diabetes Care made up 0.06% of GSA Capital Partners's portfolio in Q2 2026, its #492 holding.
- GSA Capital Partners first reported a position in Tandem Diabetes Care in Q3 2018 and has held it in 15 quarters since.
- GSA Capital Partners's Tandem Diabetes Care position peaked at $2.5M in Q1 2025.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.